Results 131 to 140 of about 1,058,979 (232)
Integrated Engineering of CAR‐T Cells for Solid Tumours
Solid tumours pose multifactorial barriers including antigen heterogeneity, immunosuppressive microenvironment, and poor T‐cell trafficking, limiting CAR‐T efficacy compared to hematologic malignancies. Integrated engineering strategies are essential, combining logic‐gated receptors for precision, metabolic‐epigenetic reprogramming for resilience, and ...
Chao Yang +5 more
wiley +1 more source
Characterization and comparison of two oncolytic poxvirus variants
reservedL’utilizzo di virus ingegnerizzati come base per lo sviluppo di vettori oncolitici e vaccini antitumorali rappresenta un approccio promettente al trattamento oncologico.
VERGANI, GILBERTO
core
Development of an oncolytic agent based on the Herpes Simplex Virus type 1 expressing the KillerRed protein targeted to the plasma membrane. [PDF]
openLa viroterapia oncologica rappresenta un promettente approccio per la cura di tumori e neoplasie solide, specialmente per quelli caratterizzati da prognosi infausta e limitata efficacia degli approcci terapeutici classici (resezione chirurgica ...
FEMMINELLA, MADDALENA
core
No abstract is available for this article.
wiley +1 more source
The role and mechanism of neutrophils in oncolytic virus therapy. [PDF]
Huang B, Yang Q, Wang R, Zhao C.
europepmc +1 more source
Oncolytic viruses: Revolutionising the fight against tumours
Zeda Zhao, Yinan Shen, Tingbo Liang
doaj +1 more source
Lei Yin,1–3 Chunhong Zhao,3 Jixia Han,4 Zengjun Li,2 Yanan Zhen,3 Ruixue Xiao,3 Zhongfa Xu,3 Yanlai Sun2 1School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, 2Department of Gastrointestinal Cancer ...
Li Z +7 more
core
Treatment sequence of stem cell delivered heterologous oncolytic virus impact on tumor microenvironment in immunocompetent ovarian cancer model. [PDF]
Abd El-Fattah EE +5 more
europepmc +1 more source
Oncolytic virus OHSV2 induces pyroptosis in bladder cancer cells via the TLR4/NLRP3/Caspase-1/GSDMD pathway. [PDF]
Xu J +9 more
europepmc +1 more source

